Skip to main content
Cureus logoLink to Cureus
. 2024 Dec 24;16(12):e76341. doi: 10.7759/cureus.76341

Tracheal Pleomorphic Adenoma With Severe Airway Obstruction

Natsumi Kushima 1,2, Daisuke Himeji 2,, Toyoshi Yanagihara 1, Kazunari Maekawa 3, Kousuke Marutsuka 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC11762010  PMID: 39867060

Abstract

Pleomorphic adenoma of the trachea is a rare benign tumor, often challenging to diagnose due to nonspecific symptoms. We report a case of a 72-year-old female with a 10-year history of presumed bronchial asthma, presenting with persistent dyspnea. Preoperative assessment for breast cancer surgery revealed severe obstructive ventilatory impairment. Further investigation with chest CT and bronchoscopy identified an intratracheal nodule, which was successfully resected using electrocautery and cryotherapy via rigid bronchoscopy. Pathological examination confirmed pleomorphic adenoma. Following the intervention, the patient’s lung function significantly improved, enabling the planned breast cancer surgery. This case highlights the importance of considering rare tracheal tumors in the differential diagnosis of refractory respiratory symptoms. A review of 11 cases of tracheal pleomorphic adenomas managed by bronchial intervention showed various endoscopic resection techniques, with electrosurgical snaring and argon plasma coagulation being the most common. Our case illustrates the effectiveness of bronchial intervention in managing tracheal tumors with severe airway obstruction and emphasizes the need for thorough preoperative assessment and heightened suspicion for rare tracheal tumors in persistent, treatment-resistant respiratory symptoms.

Keywords: airway obstruction, bronchoscopy, interventional bronchoscopy, pleomorphic adenoma, tracheal tumor

Introduction

Tracheal tumors are uncommon, accounting for less than 0.1% of all neoplasms [1]. Pleomorphic adenoma is particularly rare in this location. It typically arises in major or minor salivary glands but can occasionally develop in the palate, lips, nasal area, eyes, cheeks, and ear canal [2]. Composed of epithelial cells, myoepithelial cells, and mesenchymal components within a fibrous capsule, pleomorphic adenoma commonly appears as a slow-growing, painless, well-defined swelling [2]. However, tracheal pleomorphic adenoma presents unique diagnostic challenges due to its nonspecific symptoms and unusual location, often leading to a misdiagnosis of asthma [3].

Fewer than 50 cases of tracheal pleomorphic adenoma have been reported in medical literature to date [4]. We contribute to this limited knowledge by reporting a rare case of tracheal pleomorphic adenoma. Our patient was misdiagnosed with chronic asthma for years before the correct diagnosis was made. After accurate identification, the tumor was successfully treated with bronchoscopic interventions.

Case presentation

A 72-year-old female presented to our hospital with persistent dyspnea. Ten years earlier, she had been diagnosed with bronchial asthma but discontinued treatment due to poor response. Her medical history included hypertension, sinusitis, osteoporosis, and a left obturator hernia. She was a former smoker with a 30-pack-year history and had worked in a delicatessen.

The patient was initially referred to our surgical department for breast cancer evaluation and diagnosed with left breast cancer (cT1bN0M0; clinical stage I). During the preoperative assessment, pulmonary function tests revealed severe obstructive ventilatory impairment, prompting a referral to our respirology department.

On examination, her vital signs were as follows: temperature 36.0°C, heart rate 98 bpm, blood pressure 158/97 mmHg, respiratory rate 18/minute, and SpO2 98% on room air. Physical examination was unremarkable, with clear breath sounds bilaterally and no adventitious sounds. Initial chest X-ray showed no remarkable abnormalities (Figure 1A).

Figure 1. Chest images of the patient.

Figure 1

(A) Chest X-ray showing no apparent abnormalities in the lung fields or mediastinum. (B) Axial chest CT image showing an intratracheal tumor (black arrow).

Given her smoking history and obstructive ventilatory impairment, she was treated with a combination of inhaled corticosteroids, long-acting muscarinic antagonists, and long-acting beta-agonists; however, her condition showed minimal improvement.

Further investigation with chest CT unexpectedly revealed an intratracheal nodule (Figure 1B). Subsequent bronchoscopy identified a localized polypoid lesion in the trachea with smooth, transparent epithelium (Figure 2A).

Figure 2. Bronchoscopic images of the step-by-step resection of the tracheal tumor.

Figure 2

(A) Pre-treatment view of the polypoid tracheal tumor with a smooth, vascularized surface obstructing a significant portion of the airway lumen. (B) Application of argon plasma coagulation (APC). (C) Cryoablation is done with a cryoprobe in contact with the tumor tissue. (D) Tumor resection using an electrosurgical snare, which is looped around the base of the tumor. (E) View of the trachea immediately after tumor resection, showing the residual base of the tumor and the newly opened airway lumen. (F) Retrieval of tumor fragments using the cryoprobe. (G) Additional tumor retrieval using the snare to remove any remaining fragments. (H) After resection.

The lesion’s clear margins and lack of disruption to surrounding structures suggested an origin in the epithelial or subepithelial layer.

Under general anesthesia, we performed bronchial intervention using a DUMON rigidscope (Harada Corporation, Osaka, Japan) (outer diameter 12 mm, inner diameter 11 mm) to secure the airway. The tracheal tumor was resected using a flexible bronchoscope 1TH1200 (Olympus, Tokyo, Japan) with a high-frequency rotatable snare (No. 6183; Boston Scientific, Marlborough, MA), argon plasma coagulation (APC) probe (No. 20132-221; Erbe Elektromedizin GmbH, Tübingen, Germany), electrosurgical system (VIOD300D; No. 10140-100; Erbe Elektromedizin GmbH, Tübingen, Germany), 2.4 mm cryoprobe (No. 20402-411; Erbe Elektromedizin GmbH, Tübingen, Germany), and CRYO2 system (Erbe Elektromedizin GmbH, Tübingen, Germany) (Figure 2B‑Figure 2H). We thought that electrosurgical snaring was better to remove, such as a pedunculated large tumor, but because the tumor seemed to be abundant in blood vessels. Thus, at first, we cauterized the surface of the tumor with an APC probe to manage potential bleeding. Then, we resected the tumor by electrosurgical snaring and removed the slippery tumor from the body by cryoprobe. Pathological examination confirmed pleomorphic adenoma (Figure 3).

Figure 3. Histopathological findings of the resected tracheal tumor.

Figure 3

(A) Fragment of removed tumor. The tumor was large and had a slippery surface, so it was removed in sections. (B,C) Hematoxylin and eosin (H&E) staining showing. (B) The surface of this polypoid lesion is covered by nonneoplastic ciliated columnar epithelial cells. (C) The tumor consists of gland-forming epithelial cells, showing a double layer with basal cells, and spindle- or stellate-shaped cells with abundant myxoid or chondroid stroma. These tumor cells are irregularly admixed with each other. No apparent cellular atypism is noted.

Postoperatively, the patient’s lung function improved significantly, with forced expiratory volume in one second (FEV1) increasing from 0.58 L (35.6% of predicted) to 1.68L (103% of predicted) and peak expiratory flow improving 130 L/minute (33.3% of predicted) to 256 L/minute (64.6% of predicted) (Figure 4A and Figure 4B).

Figure 4. Pulmonary function and images before and after tracheal tumor removal.

Figure 4

(A) Pre-treatment flow-volume curve showing severe obstruction, with a flattened expiratory limb indicative of fixed upper airway obstruction. (B) Post-treatment flow-volume curve demonstrating significant improvement in airflow, with a more normal curve shape and increased peak expiratory flow rate. (C) Pre-treatment and (D) four months after treatment of chest CT images. The large tumor obstructing most of the trachea (black arrow) was removed (black triangle).

This improvement allowed her to proceed with the planned breast cancer surgery one and a half months after tumor resection. A follow-up chest CT four months post-resection showed no signs of tracheal recurrence (Figure 4C and Figure 4D).

Discussion

Pleomorphic adenoma is a benign mixed tumor composed of three components: epithelial, myoepithelial, and mesenchymal elements [2]. Primarily associated with salivary glands, its occurrence in the lungs, trachea, and bronchi is extremely rare, accounting for only 2% to 9% of all cases [5]. A comprehensive 34-year, single-institution study of 164 primary salivary gland-type tumors in the tracheobronchial tree highlights this rarity, with pleomorphic adenoma representing just 1.8% of cases, far behind adenoid cystic carcinoma (137 cases, 83.5%) and mucoepidermoid carcinoma (21 cases, 12.8%) [6]. The clinical course of these tumors can be prolonged, with a median symptom duration of 5.5 months; however, cases lasting up to a decade have been reported [4]. Symptoms, often including wheezing, cough, and dyspnea, frequently lead to a misdiagnosis of bronchial asthma. This was evident in our case, where the patient’s symptoms were initially attributed to asthma for an extended period. This case underscores the need to consider rare tracheal tumors in the differential diagnosis of persistent respiratory symptoms, especially when conventional treatments prove ineffective.

Management of tracheal pleomorphic adenoma primarily involves complete surgical resection. However, endoscopic resection using techniques such as APC and electrocautery also has been successful. A review of 11 cases, including ours, of tracheal pleomorphic adenomas managed through bronchial interventions is summarized in Table 1 [3-5,7-13].

Table 1. Summary of bronchial intervention for tracheal pleomorphic adenomas.

APC, argon plasma coagulation

Reference Year Age Sex Tumor size (cm) Tumor site Resection method Clinical follow-up period (months) Outcome
Matsubara et al. [7] 2008 71 M Not available Left main bronchus Electrosurgical snaring and APC Six No recurrence
Fitchett et al. [5] 2008 65 M 1.3 Right main bronchus Diathermy snare Not available Not available
Kajikawa et al. [8] 2010 55 M Not available Lower trachea APC, electrocautery and rigid bronchoscopic coring Seven No recurrence
Goto et al. [9] 2011 71 M 2.5 × 2 Left main bronchus Electrosurgical snaring Two No recurrence
Casillas-Enriquez et al. [10] 2014 33 F 80% occlusion Upper trachea APC Eight No recurrence
Sim et al. [13] 2014 32 F 1.8 × 1.6 Lower trachea Rigid forceps and APC One No recurrence
Zhu et al. [11] 2018 38 F 1.42 × 0.96 Right main bronchus Electrosurgical snaring and APC Three No recurrence
Takahashi et al. [3] 2019 51 F 1.5 Upper trachea Electrosurgical snaring and forceps 30 No recurrence
David et al. [12] 2020 83 F 1.6 × 1.3 Upper trachea Fiber-based CO2 laser and rigid bronchoscope Not available Not available
Liao et al. [4] 2020 49 F 2.4 × 2.1 Lower trachea Electrosurgical snare, cryotherapy, and APC Three No recurrence
Our case 2023 72 F 1.5 × 1.2 × 1.7 Lower trachea Electrosurgical snare, APC, cryotherapy, and rigid bronchoscope 15 No recurrence

Patient ages ranged from 32 to 83 years (median 55), with a slight female predominance in recent cases. More than half of the cases had a previous diagnosis of obstructive lung disease (data not shown). Tumors varied in location throughout the tracheobronchial tree, ranging in size from 1.3 cm to 2.5 × 2 cm, with our case measuring 1.5 × 1.2 × 1.7 cm. In the literature presented in Table 1, although some reports did not clearly document the reasons for choosing endoscopic resection over surgical resection, bronchoscopic resection was selected for reasons such as patient preference against surgery [7], the tracheal tumor was smaller than the tracheal diameter, and there was thought to be no risk of tracheal obstruction due to resection [3] and the procedure being less invasive with faster postoperative recovery [4]. We believe that surgical resection is the preferred treatment for tracheal tumors when a definitive diagnosis has been made, the respiratory status is stable, and the extent of resection is feasible. However, in cases where airway stenosis caused by the tumor at the time of presentation was severe, transbronchial biopsy for definitive diagnosis will be risky for those patients. In such cases, we believe that it will be better to first secure the airway endoscopically and then consider additional treatments, such as surgical resection, based on the degree of curability with endoscopic treatment, the results of definitive diagnosis, and an assessment of surgical resectability.

Various endoscopic resection techniques were used, often in combination. Electrosurgical snaring was the most common (seven of 11 cases), frequently complemented with APC (six cases). Other methods included rigid bronchoscopy, forceps, cryotherapy, and, in one instance, fiber-based CO2 laser. We use a rigid bronchoscope to secure the airway. We resected the tumor with an electrosurgical snaring and managed to bleed with APC, as in the majority of the other cases in Table 1. A cryoprobe was used for removing from the body through rigidscope. In our case, bronchial intervention proved effective, allowing for tumor removal while preserving tracheal function.

In cases of incomplete resection, recurrence and malignant transformation are possible [14]. There are few reports of long-term follow-up after excisional treatment of tracheal pleomorphic adenoma, so the rate and timing of recurrence are unknown. A case of tracheal pleomorphic adenoma was reported as recurrent in 2020, following surgical resection and end-to-end anastomosis performed 10 years earlier [15]. We would like to follow this patient by periodic chest CT and flexible bronchoscopy at least 10 years after the tumor resection.

This case illustrates several key points. First, it emphasizes the importance of thorough preoperative assessment, including imaging studies, in patients with persistent respiratory symptoms. Second, it highlights the need for a high index of suspicion for rare tracheal tumors in cases of refractory "asthma." Last, it demonstrates the effectiveness of bronchial intervention techniques in managing tracheal tumors, even in cases with severe airway obstruction.

Conclusions

While pleomorphic adenoma commonly occurs in salivary glands, its occurrence in the trachea is exceptionally rare. The tumor occurring in the trachea typically presents with obstructive airway symptoms that can mimic asthma and lead to misdiagnosis. Despite limited consensus on management and prognosis due to its rarity, bronchoscopic tumor resection can be highly effective, as demonstrated in our case. Early recognition and appropriate intervention can lead to favorable outcomes and improved quality of life. Long-term follow-up is essential to monitor for recurrence and potential malignant transformation.

Disclosures

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Author Contributions

Concept and design:  Daisuke Himeji, Natsumi Kushima, Toyoshi Yanagihara

Acquisition, analysis, or interpretation of data:  Daisuke Himeji, Kousuke Marutsuka, Kazunari Maekawa

Drafting of the manuscript:  Daisuke Himeji, Natsumi Kushima, Toyoshi Yanagihara, Kousuke Marutsuka, Kazunari Maekawa

Critical review of the manuscript for important intellectual content:  Daisuke Himeji, Kousuke Marutsuka

Supervision:  Daisuke Himeji, Kousuke Marutsuka, Kazunari Maekawa

References

  • 1.Primary tracheal tumours. Macchiarini P. Lancet Oncol. 2006;7:83–91. doi: 10.1016/S1470-2045(05)70541-6. [DOI] [PubMed] [Google Scholar]
  • 2.A review of the current literature on pleomorphic adenoma. Kalwaniya DS, Meena R, Kumar D, Tolat A, Arya SV. Cureus. 2023;15:0. doi: 10.7759/cureus.42311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.A case of tracheal pleomorphic adenoma misdiagnosed as asthma. Takahashi M, Yorozuya T, Miyasaka Y, et al. Oxf Med Case Reports. 2019;2019:457–460. doi: 10.1093/omcr/omz111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pleomorphic adenoma of the trachea: a case report and review of the literature. Liao QN, Fang ZK, Chen SB, et al. World J Clin Cases. 2020;8:6026–6035. doi: 10.12998/wjcc.v8.i23.6026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.A rare case of primary pleomorphic adenoma in main bronchus. Fitchett J, Luckraz H, Gibbs A, O'Keefe P. Ann Thorac Surg. 2008;86:1025–1026. doi: 10.1016/j.athoracsur.2008.02.073. [DOI] [PubMed] [Google Scholar]
  • 6.Tracheobronchial gland tumors. Gaissert HA, Mark EJ. Cancer Control. 2006;13:286–294. doi: 10.1177/107327480601300406. [DOI] [PubMed] [Google Scholar]
  • 7.Pleomorphic adenoma with an endobronchial resection. Matsubara M, Yasuo M, Tanabe T, et al. Intern Med. 2008;47:1117–1120. doi: 10.2169/internalmedicine.47.0853. [DOI] [PubMed] [Google Scholar]
  • 8.Pleomorphic adenoma of the trachea. Kajikawa S, Oki M, Saka H, Moritani S. Respiration. 2010;80:433–434. doi: 10.1159/000308462. [DOI] [PubMed] [Google Scholar]
  • 9.Bronchial pleomorphic adenoma coexisting with lung cancer. Goto T, Maeshima A, Akanabe K, Hamaguchi R, Wakaki M, Oyamada Y, Kato R. Ann Thorac Cardiovasc Surg. 2011;17:174–177. doi: 10.5761/atcs.cr.09.01516. [DOI] [PubMed] [Google Scholar]
  • 10.Pleomorphic adenoma of the trachea: a case report. Casillas-Enríquez JD, Álvarez-Maldonado P, Salguero-Cruz L, Navarro-Reynoso F, Cicero-Sabido R, Núñez-Pérez Redondo C. J Bronchology Interv Pulmonol. 2014;21:51–53. doi: 10.1097/LBR.0000000000000025. [DOI] [PubMed] [Google Scholar]
  • 11.Right main bronchial pleomorphic adenoma: a case report and literature review. Zhu Z, Lian X, Yang D. Medicine (Baltimore) 2018;97:0. doi: 10.1097/MD.0000000000012648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pleomorphic adenoma of the trachea. David AP, Bakos SR, Daniero JJ. Ear Nose Throat J. 2020;99:235–236. doi: 10.1177/0145561319840189. [DOI] [PubMed] [Google Scholar]
  • 13.Pleomorphic adenoma of the trachea. Sim DW, Oh IJ, Kim KS, Choi YD, Kwon YS. J Bronchology Interv Pulmonol. 2014;21:230–233. doi: 10.1097/LBR.0000000000000076. [DOI] [PubMed] [Google Scholar]
  • 14.Carcinoma ex pleomorphic adenoma of the trachea: a case report. Gao HX, Li Q, Chang WL, Zhang YL, Wang XZ, Zou XX. World J Clin Cases. 2019;7:2623–2629. doi: 10.12998/wjcc.v7.i17.2623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Palliative treatment of recurrent tracheal pleomorphic adenoma 10 years after segmental resection using the endobronchial shaver. Karamustafaoglu YA, Yanık F, Yoruk Y. Clin Respir J. 2020;14:495–497. doi: 10.1111/crj.13149. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES